We then compared the effect of single gene knockout of SERPINB3 on radiosensitivity with or without cisplatin chemotherapy, the radiosensitizing agent used as standard of care for the treatment of patients with cervical cancer. This evidence concerns the gene SERPINB3 and cervical carcinoma.